News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,605 Results
Type
Article (41342)
Company Profile (265)
Press Release (688982)
Multimedia
Podcasts (92)
Webinars (20)
Section
Business (204838)
Career Advice (2032)
Deals (35582)
Drug Delivery (128)
Drug Development (81512)
Employer Resources (173)
FDA (16507)
Job Trends (14981)
News (346812)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2595)
Accelerated approval (47)
Adcomms (26)
Allergies (171)
Alliances (49579)
ALS (210)
Alzheimer's disease (1793)
Antibody-drug conjugate (ADC) (442)
Approvals (16884)
Artificial intelligence (657)
Autoimmune disease (289)
Automation (56)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (220)
Biotechnology (175)
Bladder cancer (187)
Brain cancer (71)
Breast cancer (747)
Cancer (5785)
Cardiovascular disease (467)
Career advice (1724)
Career pathing (42)
CAR-T (330)
CDC (56)
Celiac Disease (3)
Cell therapy (895)
Cervical cancer (47)
Clinical research (70782)
Collaboration (2045)
Company closure (5)
Compensation (1388)
Complete response letters (79)
COVID-19 (2741)
CRISPR (107)
C-suite (1113)
Cystic fibrosis (152)
Data (7838)
Decentralized trials (3)
Denatured (27)
Depression (160)
Dermatology (86)
Diabetes (586)
Diagnostics (6926)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (316)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92062)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119459)
Executive appointments (1077)
FDA (20213)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1715)
Gene editing (233)
Generative AI (56)
Gene therapy (718)
GLP-1 (1052)
Government (4729)
Grass and pollen (6)
Guidances (408)
Healthcare (18994)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (287)
Immuno-oncology (92)
Indications (191)
Infectious disease (3078)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (319)
IPO (16667)
IRA (50)
Job creations (3647)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (99)
Layoffs (562)
Leadership (39)
Legal (7953)
Liver cancer (99)
Longevity (32)
Lung cancer (760)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1043)
MASH (185)
Medical device (13925)
Medtech (14046)
Mergers & acquisitions (20157)
Metabolic disorders (1493)
mRNA (204)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (412)
Neuropsychiatric disorders (105)
Neuroscience (3293)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4530)
Now hiring (78)
Obesity (698)
Opinion (286)
Ovarian cancer (218)
Pain (252)
Pancreatic cancer (299)
Parkinson's disease (358)
Partnered (33)
Patents (592)
Patient recruitment (667)
Peanut (62)
People (59562)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22066)
Phase 2 (31184)
Phase 3 (23205)
Pipeline (8661)
Policy (314)
Postmarket research (2568)
Preclinical (9404)
Press Release (64)
Prostate cancer (298)
Psychedelics (54)
Radiopharmaceuticals (320)
Rare diseases (1070)
Real estate (5969)
Recruiting (70)
Regulatory (25374)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (288)
Series B (212)
Service/supplier (11)
Sickle cell disease (112)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3639)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1088)
Venture capital (107)
Weight loss (450)
Women's health (125)
Worklife (20)
Date
Today (189)
Last 7 days (855)
Last 30 days (3572)
Last 365 days (30189)
2026 (12354)
2025 (30170)
2024 (35211)
2023 (40073)
2022 (51175)
2021 (55707)
2020 (54081)
2019 (46537)
2018 (35015)
2017 (32107)
2016 (31479)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39660)
Australia (6502)
California (13238)
Canada (3759)
China (1332)
Colorado (566)
Connecticut (574)
Delaware (403)
Europe (85820)
Florida (1980)
Georgia (424)
Hawaii (3)
Idaho (62)
Illinois (1050)
India (90)
Indiana (598)
Iowa (23)
Japan (534)
Kansas (131)
Kentucky (50)
Louisiana (40)
Maine (76)
Maryland (1585)
Massachusetts (9434)
Michigan (362)
Minnesota (715)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (84)
New Jersey (3478)
New Mexico (29)
New York (3456)
North Carolina (1678)
North Dakota (9)
Northern California (6639)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2661)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5218)
Tennessee (210)
Texas (2098)
United States (46657)
Utah (393)
Vermont (1)
Virginia (321)
Washington D.C. (80)
Washington State (1056)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
730,605 Results for "pulmonx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
Pulmonx Announces Treatment of the First Patient with the AeriSeal ® System in CONVERT II Pivotal Trial.
February 26, 2024
·
7 min read
Business
Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023
Pulmonx Corporation, a global leader in minimally invasive treatments for lung disease, announced that it will release financial results for the first quarter of 2023 after the close of trading on Tuesday, May 2, 2023.
April 18, 2023
·
1 min read
Press Releases
Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 13, 2026
·
3 min read
Press Releases
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
·
10 min read
Press Releases
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026
·
6 min read
Press Releases
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer
May 14, 2026
·
4 min read
Business
Pulmonx to Report Second Quarter 2022 Financial Results on August 2, 2022
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2022 after the close of trading on Tuesday, August 2, 2022.
July 19, 2022
·
1 min read
Biotech Bay
Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming Canaccord Genuity 42nd Annual Growth Conference in Boston.
July 27, 2022
·
1 min read
Press Releases
COSCIENS Biopharma Inc. Reports Q1 2026 Results
May 13, 2026
·
8 min read
Biotech Bay
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the Zephyr ® Endobronchial Valve for treating severe COPD/emphysema patients.
November 30, 2022
·
7 min read
1 of 73,061
Next
